Mortality for Certain Diseases in Areas with High Levels of Arsenic in Drinking Water

Archives of Environmental Health

Volumn 54, Issue 3, 1999, Pages 186-193

  Tsai, Shih Meng ^a   Wang, Tsu Nai ^a   Ko, Ying Chin ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER;

ARTICLE; BRONCHITIS; CANCER MORTALITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; EXPOSURE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; TAIWAN; WATER POLLUTANT; WATER POLLUTION; WATER SUPPLY;

MELAMPODIUM;

EID: 0033060359     PISSN: 00039896     EISSN: None     Source Type: Journal    
DOI: 10.1080/00039899909602258     Document Type: Article

References (38)

1. Smith AH, Hopenhayn-Rich C, Bates MN, et al. Cancer risk from arsenic in drinking water. Environ Health Perspect 1992, 97: 259-67
2. Bates MN, Smith AH, Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1992, 135:462-76
3. Enterline PE, Day R, Marsh CM. Cancers related to exposure to arsenic at copper smelters. Occup Environ Med 1995, 52: 28-32
4. Chen CJ, Chuang YC, Lin TM, et al. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well waters and cancers. Cancer Res 1985, 45:5895-99
5. Tsuda T, Babazono A, Yamamoto E, et al. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 1995 141:198-209
6. Bulbulyan MA, Jurenkova NJ, Boffetta P, et al. Mortality in a cohort of Russian fertilizer workers. Scand J Work Environ Health 1996, 22:27-33
7. Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 1995, 141:523-29
8. Tomatis L, Aitio A, Wilbourn J, et al. Human carcinogens so far identified. Japan J Cancer Res 1989, 80:795-807
9. Battista C, Bartoli D, laia TE, et al. Art glassware and sinonasal cancer: report of three cases. Am J Ind Med 1996, 30:31-35
10. Lai MS, Hsueh YM, Chen CJ, et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994, 139: 484-92
11. Chen CJ, Chiou HY, Chiang MH, et al. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vase Biol 1996, 16: 504-10
12. Durant JL, Chen J, Hemond HF, etal. Elevated incidence of childhood leukemia in Woburn, Massachusetts: NIEHS superfund basic research program searches for causes. Environ Health Per-spect 1995, 103:93-98
13. Chen CJ, Hsueh YM, Lai MS, et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995, 25: 53-60
14. Wu MM, Kuo TL, Hwang YH, et al. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989, 130: 1123-32
15. Warner ML, Moore LE, Smith MT, et al. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomark Prev 1994, 3:583-90
16. Moore LE, Smith AH, Hopenhayn-Rich C, et al. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomark Prevent 1997, 6:31-36
17. Hantson P, Verellen-Dumoulin C, Libouton JM, et al. Sister chromatid exchanges in human peripheral blood lymphocytes after ingestion of high doses of arsenicals. Int Arch Occup Environ Health 1996, 68:342-44
18. Lerda D. Sister-chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mutat Res 1994, 312:111-20
19. Lee TC, Ho IC. Differential cytotoxic effects of arsenic on human and animal cells. Environ Health Perspect 1994, 102:101-05
20. Ramos O, Carrizales L, Yanesz L, et al. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environ Health Perspect 1995, 103(suppl 1): 85-88
21. Tseng WP. Blackfoot disease in Taiwan: a 30-year follow-up study. J Vase Dis 1989, 7:547-58
22. Wu HY, Chen KP, Tseng WP, et al. Epidemiologic studies on blackfoot disease. 1. Prevalence and incidence of the disease by age, sex, year, occupation, and geographic distribution. Mem Coll Med Natl Taiwan Univ 1961, 7:33-50
23. Tseng WP, Chu HM, How SW, et al. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. JNCI 1968, 40:453-63
24. Chen KP, Wu HY, Wu TC. Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease area. Mem Coll Med Natl Taiwan Univ 1962, 8:115-19
25. Lo MC. The arsenic content of farm products and fish in areas where high arsenic well water was used for agriculture and pisciculture. Report on Blackfoot Disease Research. Taiwan, ROC: Taiwan Provincial Government, 1978, 6:28-46
26. Blackwell RQ. Estimated total arsenic ingested by residents in the endemic blackfoot area. J Formosan Med Assoc 1961, 60: 1143-44
27. Ministry of Interior, Republic of China. Demographic Facts, 1971-1994. Taipei, ROC: Ministry of Interior
28. Chen CJk, Wu MM, Lee SS, et al. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasm of blackfoot disease. Arteriosclerosis 1986, 8:452-60
29. Rothman KJ. Stratified analysis. Modern Epidemiology. Boston, Ma: Little, Brown, 1986
30. Malker HSR, McLaughlin JK, Weiner JA, et al. Occupational risk factors for nasopharyngeal cancer in Sweden. Br J Ind Med 1990, 47:213-14
31. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 1990, 50:5470-74
32. Kadowski K. Studies on the arsenic contents in organ tissues of the normal Japanese. Osaka City Med J 1960, 9:2083-88
33. Rathman M, Axelson O. Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter, occup Environ Med 1995, 25:773-74
34. Tseng CH, Chong CK, Chen CJ, et al. Abnormal peripheral microcirculation in seemingly normal subjects living in black-foot-disease-hyperendemic villages in Taiwan. Int J Cicrocirc 1995, 15:21-27
35. Lu FJ. Blackfoot disease: arsenic or humic acid? Lancet 1990, 336:115-16
36. Hopenhayn-Rich C, Biggs ML, Fuchs A, et al. Bladder cancer mortality associated with arsenic drinking water in Argentina. Epidemiology 1996, 7:117-24
37. Tseng CH, Chong CK, Chen CJ, et al. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 1996, 120:125-33
38. Engel RR, Smith AH. Arsenic in drinking water and mortality from vascular disease: an ecologie analysis in 30 counties in the United States. Arch Environ Health 1994, 49:418-27